Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Neurological Medicine
Volume 2016, Article ID 7464587, 3 pages
http://dx.doi.org/10.1155/2016/7464587
Case Report

A Case Report of Neurosarcoidosis Presenting as a Lymphoma Mimic

Department of Neurology, Stony Brook University Hospital, Stony Brook, NY, USA

Received 10 April 2016; Accepted 14 August 2016

Academic Editor: Samuel T. Gontkovsky

Copyright © 2016 Gurcharanjeet Kaur et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Gullapalli and L. H. Phillips II, “Neurologic manifestations of sarcoidosis,” Neurologic Clinics, vol. 20, no. 1, pp. 59–83, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. T. M. Burns, “Neurosarcoidosis,” Archives of Neurology, vol. 60, no. 8, pp. 1166–1168, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. B. J. Stern, A. Krumholz, C. Johns, P. Scott, and J. Nissim, “Sarcoidosis and its neurological manifestations,” Archives of Neurology, vol. 42, no. 9, pp. 909–917, 1985. View at Publisher · View at Google Scholar · View at Scopus
  4. J. P. Zajicek, N. J. Scolding, O. Foster et al., “Central nervous system sarcoidosis—diagnosis and management,” Quarterly Journal of Medicine, vol. 92, no. 2, pp. 103–117, 1999. View at Publisher · View at Google Scholar
  5. M. H. Hodge, R. L. Williams, and M. B. Fukui, “Neurosarcoidosis presenting as acute infarction on diffusion-weighted MR imaging: summary of radiologic findings,” American Journal of Neuroradiology, vol. 28, no. 1, pp. 84–86, 2007. View at Google Scholar · View at Scopus
  6. J. McAfoose and B. T. Baune, “Evidence for a cytokine model of cognitive function,” Neuroscience and Biobehavioral Reviews, vol. 33, no. 3, pp. 355–366, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Hoitsma, C. G. Faber, M. Drent, and O. P. Sharma, “Neurosarcoidosis: a clinical dilemma,” The Lancet Neurology, vol. 3, no. 7, pp. 397–407, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. B. T. Baune, F. Wiede, A. Braun, J. Golledge, V. Arolt, and H. Koerner, “Cognitive dysfunction in mice deficient for TNF- and its receptors,” American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, vol. 147, no. 7, pp. 1056–1064, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. M. D. Elfferich, P. J. Nelemans, R. W. Ponds, J. De Vries, P. A. Wijnen, and M. Drent, “Everyday cognitive failure in sarcoidosis: the prevalence and the effect of anti-TNF-α treatment,” Respiration, vol. 80, no. 3, pp. 212–219, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Moravan and B. M. Segal, “Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil,” Neurology, vol. 72, no. 4, pp. 337–340, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Hoitsma, C. G. Faber, M. van Santen-Hoeufft, J. De Vries, J. P. H. Reulen, and M. Drent, “Improvement of small fiber neuropathy in a sarcoidosis patient after treatment with infliximab,” Sarcoidosis Vasculitis and Diffuse Lung Diseases, vol. 23, no. 1, pp. 73–77, 2006. View at Google Scholar · View at Scopus